Top

World Journal of Urology

Published in:

01-12-2013 | Topic paper

Re-irradiation for salvage of prostate cancer failures after primary radiotherapy

Authors: Stephen J. Ramey, David T. Marshall

Published in: World Journal of Urology | Issue 6/2013

Abstract

Purpose

To review the literature on use of radiation as a salvage option after local-only failure following initial treatment with radiation.

Methods

PubMed was searched from inception to June 2012 using terms designed to include relevant articles on salvage radiation as a treatment for local-only failures after radiation.

Results

Eighteen separate studies were found which demonstrated widely different patient populations, treatment methods, follow-up periods, and reporting. Only one phase II prospective study was found with no randomized controlled trials. Biochemical disease-free survival (bDFS) at four to 5 years ranged from 20 to 75 %. Patient selection may have influenced these varying rates since some studies with lower bDFS had higher risk populations. Factors associated with improved bDFS included post-treatment prostate-specific antigen (PSA) nadir of <0.5 ng/mL, pre-salvage PSA <6, Gleason score ≤7, and PSA doubling time (PSADT) >10 months. Overall survival ranged from 54 to 94 %, and disease-specific survival ranged from 74 to 100 %. The crude rate of grade 3–4 genitourinary toxicities among all studies was 13 % (range 0–47 %), and the crude rate of grade 3–4 gastrointestinal toxicities was 5 % (range 0–20 %). Incontinence rates were low among reviewed studies at 4 % (range 0–29 %).

Conclusions

Brachytherapy represents a reasonable salvage option for patients with local recurrence after initial radiotherapy for prostate cancer. However, rates of toxicities, as in other salvage treatments, can be fairly high, and the likelihood of death from prostate recurrence variable. Prospective studies are needed to better define the efficacy and toxicity of this treatment modality.

American Cancer Society (2012) Cancer Facts & Figures 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed 6/24/12

Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117(7):1429–1437. doi:10.1002/cncr.25467 PubMedCrossRef

Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC (2011) Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 81(2):376–381. doi:10.1016/j.ijrobp.2010.05.042 PubMedCrossRef

Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL (2003) Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57(4):915–928PubMedCrossRef

Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, Ma C (2011) 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 80(5):1323–1329. doi:10.1016/j.ijrobp.2010.04.038 PubMedCrossRef

Sylvester J, Grimm P, Blasko J, Meier R, Heaney C, Cavanaugh WA (2001) Transperineal permanent brachytherapy for local recurrence following external beam radiation for early-stage prostate cancer. J Brachytherapy Int 17:181–188

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2007) Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol Off J Am Soc Clin Oncol 25(13):1765–1771. doi:10.1200/jco.2006.08.0572 CrossRef

Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL (2008) Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol 26(1):9–16. doi:10.1016/j.urolonc.2006.12.016 PubMedCrossRef

Clarke HS Jr, Eskridge MR, El-Zawahry AM, Keane TE (2007) Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm. Can J Urol 14(Suppl 1):24–27PubMed

10.

Finley DS, Belldegrun AS (2011) Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications. Curr Urol Reports 12(3):209–215. doi:10.1007/s11934-011-0182-4 CrossRef

11.

Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B (2011) High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (Royal College of Radiologists (Great Britain)) 23 (2):117–127 doi:10.1016/j.clon.2010.09.002

12.

Beyer DC (2003) Brachytherapy for recurrent prostate cancer after radiation therapy. Sem Rad Oncol 13(2):158–165. doi:10.1053/srao.2003.50015 CrossRef

13.

Nguyen PL, D’Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7):1417–1428. doi:10.1002/cncr.22941 PubMedCrossRef

14.

Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A (2011) EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4):572–583. doi:10.1016/j.eururo.2011.01.025 PubMedCrossRef

15.

Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA (2009) Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer 115(19):4470–4476. doi:10.1002/cncr.24526 PubMedCrossRef

16.

Crook JM, Choan E, Perry GA, Robertson S, Esche BA (1998) Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology 51(4):566–572PubMedCrossRef

17.

Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M 3rd, Shinohara K (2009) Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int 104(5):600–604. doi:10.1111/j.1464-410X.2009.08445.x PubMedCrossRef

18.

Allen GW, Howard AR, Jarrard DF, Ritter MA (2007) Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer 110(7):1405–1416. doi:10.1002/cncr.22940 PubMedCrossRef

19.

Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54(5):880–883PubMedCrossRef

20.

Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77(5):1338–1344. doi:10.1016/j.ijrobp.2009.06.061 PubMedCrossRef

21.

Cumes DM, Goffinet DR, Martinez A, Stamey TA (1981) Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy. J Urol 126(5):620–622PubMed

22.

Dattoli M, Cash J, Ross R, Geohagen B, Palm J, Koval J, Sorace R (1997) Neoadjuvant hormone therapy and palladium-103 brachytherapy as salvage for locally recurrent prostate cancer. Proc Am Soc Clin Oncol 16:1118. (Abstract)

23.

Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, Larson TR, Wilkes MM, Navickis RJ (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53(1):2–10PubMedCrossRef

24.

Jo Y, Fujii T, Hara R, Yokoyama T, Miyaji Y, Yoden E, Hiratsuka J, Nagai A (2012) Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy: preliminary results. BJU Int 109(6):835–839. doi:10.1111/j.1464-410X.2011.10519.x PubMedCrossRef

25.

Koutrouvelis P, Hendricks F, Lailas N, Gil-Montero G, Sehn J, Khawand N, Bondy H, Katz S (2003) Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2(4):339–344PubMed

26.

Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M 3rd, Hsu IC (2007) Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67(4):1106–1112. doi:10.1016/j.ijrobp.2006.10.012 PubMedCrossRef

27.

Lee HK, Adams MT, Motta J (2008) Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 7(1):17–21. doi:10.1016/j.brachy.2007.11.002 PubMedCrossRef

28.

Loening SA, Turner JW (1993) Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 23(4):283–290PubMedCrossRef

29.

Moman MR, van der Poel HG, Battermann JJ, Moerland MA, van Vulpen M (2010) Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy 9(2):119–125. doi:10.1016/j.brachy.2009.06.007 PubMedCrossRef

30.

Nguyen PL, Chen MH, D’Amico AV, Tempany CM, Steele GS, Albert M, Cormack RA, Carr-Locke DL, Bleday R, Suh WW (2007) Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110(7):1485–1492. doi:10.1002/cncr.22934 PubMedCrossRef

31.

Teh BS, Berner BM, Carpenter LS, Chiu JK, Dennis WS, Lu HH, Woo SY, Butler EB (1998) Permanent Gold-198 Implant for locally recurrent adenocarcinoma of the prostate after failing initial radiotherapy. J Brachytherapy Int 14:233–240

32.

Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J (2008) Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 7(3):231–236. doi:10.1016/j.brachy.2008.03.003 PubMedCrossRef

33.

Wallner KE, Nori D, Morse MJ, Sogani PC, Whitmore WF, Fuks Z (1990) 125iodine reimplantation for locally progressive prostatic carcinoma. J Urol 144(3):704–706PubMed

34.

Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ (2006) Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 176(5):2020–2024. doi:10.1016/j.juro.2006.07.008 PubMedCrossRef

35.

Butler EB, Scardino PT, Teh BS, Uhl BM, Guerriero WG, Carlton CE, Berner BM, Dennis WS, Carpenter LS, Lu HH, Chiu JK, Kent TS, Woo SY (1997) The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncol 13(6):406–418PubMedCrossRef

Title: Re-irradiation for salvage of prostate cancer failures after primary radiotherapy
Authors: Stephen J. Ramey
David T. Marshall
Publication date: 01-12-2013
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 6/2013
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-012-0953-7

At a glance: The STEP trials

Springer Medicine

Re-irradiation for salvage of prostate cancer failures after primary radiotherapy

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2013

Percutaneous nephrolithotomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system

Is stone diameter a variable in the decision process of employing a ureteral stent in patients undergoing uncomplicated ureterorenoscopy and associated intracorporeal lithotripsy?

The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders

Improved laparoscopic treatment of symptomatic urachal anomalies

Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells

Impact of intermittent catheterization on the quality of life of multiple sclerosis patients